Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Colorectal Neoplasms × Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 1 Sarcoma 1 Melanoma 1 Glioblastoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Bevacizumab 59 Cetuximab 41 Fluorouracil 39 pembrolizumab 30 Oxaliplatin 30 Leucovorin 27 Irinotecan 24 Folfox protocol 20 Specimen Handling 18 HMPL-013 17 Capecitabine 17 Blood Specimen Collection 16 trifluridine tipiracil drug combination 13 Magnetic Resonance Spectroscopy 13 Biopsy 11 regorafenib 10 Trifluridine 10 Panitumumab 10 Gemcitabine 10 Carboplatin 10 Nivolumab 9 IFL protocol 9 Drug Therapy 9 Cisplatin 9 encorafenib 8 Standard of Care 8 Interviews as Topic 8 sintilimab 7 Radiosurgery 7 Cyclophosphamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06522919 2025-01-28

CombiCoR-Vax

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡